Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced the acceptance of multiple abstracts for presentation at three significant upcoming congresses focusing on angioedema, ...

BRISBANE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted ...

Arbutus Biopharma Corporation announced that five abstracts, including a late-breaker, have been accepted for poster presentations at the EASL Congress 2025 in Amsterdam from May 7 to 10, 2025. The ...

Abstracts for oral presentations should be submitted by March 9, 2026. AATCC reserves the right to accept, place on a waiting ...

You must submit your abstract using the online submission form. Abstracts sent by email will not be considered. Abstracts that are incomplete will not be considered. All ESA Annual Meeting proposal ...

A lightning talk is a very short presentation on a timely topic of interest to the audience. Lightning talks are 2-3 minutes with just 1-2 slides, followed by a group discussion. The main goals of the ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that more than 40 abstracts highlighting data from eight of its hematology and oncology products will be presented at the ...

BERKELEY HEIGHTS, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) will present data from its oncology portfolio at the upcoming 64 th American Society of Hematology Annual Meeting (ASH 2022), held December ...

The American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH) annual meetings are two of the largest conferences in the fields of hematology and oncology. These ...